Background: Activity-related knee discomfort is common in endurance-trained adults. Multi-ingredient supplements targeting complementary biological pathways may support knee comfort and load tolerance in this population, but controlled evidence is limited. Methods: In this randomized, double-blind, placebo- and active-comparator-controlled pilot trial, 60 endurance-trained adults (20 per group) with activity-related knee discomfort received for 12 weeks either a multi-ingredient formula (undenatured type II collagen, curcumin phytosome, and enzymatically hydrolyzed bone powder; Group A), glucosamine hydrochloride plus chondroitin sulfate (Group B), or placebo (Group C). Assessments of functional and patient-reported outcomes were conducted at baseline, week 6, week 12, and 24 h after a post-intervention half-marathon challenge. Outcome measures covered functional pain tolerance, patient-reported pain symptoms, exploratory biomarkers of cartilage turnover, inflammation, and oxidative stress. Results: Group-by-time interactions were significant for SLSD repetitions to pain levels 2 and 5 and for VAS (all p < 0.0001). At week 12, Group A exceeded placebo for the SLSD repetitions to pain level 5 (mean difference 30.5 repetitions; 95% CI 8.7 to 52.3; p = 0.0201), for SLSD repetitions to pain level 2 (21.4; 8.8 to 34.1; p = 0.0037), and for VAS (−1.6; −2.6 to −0.7; p = 0.0030), whereas Group B differed from placebo for SLSD pain level 2 and VAS but not for the SLSD pain level 5. No direct comparison between Groups A and B was statistically significant (all adjusted p > 0.05). After the half-marathon, only Groups B and C showed significant within-group declines in ROM relative to baseline (p = 0.0262 and p = 0.0147), whereas Group A did not (p > 0.99), although between-group ROM contrasts were not significant. Biomarker changes were exploratory, and no between-group biomarker difference reached significance. Conclusions: In this pilot trial, 12 weeks of multi-ingredient supplementation improved pain-limited knee load tolerance and self-reported knee pain relative to placebo in endurance-trained adults. These results require confirmation in a larger trial.